rs362562

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_130811.4(SNAP25):c.-63-12891G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.362 (AC=54,961) in the gnomAD database across 151,862 control chromosomes, including 10,738 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.427. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10738 hom., cov: 32)

Consequence

SNAP25
NM_130811.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.138

Publications

5 publications found
Variant links:
Genes affected
SNAP25 (HGNC:11132): (synaptosome associated protein 25) Synaptic vesicle membrane docking and fusion is mediated by SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) located on the vesicle membrane (v-SNAREs) and the target membrane (t-SNAREs). The assembled v-SNARE/t-SNARE complex consists of a bundle of four helices, one of which is supplied by v-SNARE and the other three by t-SNARE. For t-SNAREs on the plasma membrane, the protein syntaxin supplies one helix and the protein encoded by this gene contributes the other two. Therefore, this gene product is a presynaptic plasma membrane protein involved in the regulation of neurotransmitter release. Two alternative transcript variants encoding different protein isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
SNAP25 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 18
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
SNAP25-AS1 (HGNC:44312): (SNAP25 antisense RNA 1) Predicted to be involved in SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition. Predicted to be part of signal recognition particle, endoplasmic reticulum targeting. [provided by Alliance of Genome Resources, Jul 2025]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_130811.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.4269 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_130811.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

SNAP25 NM_130811.4
MANE Select
HGVSc / HGVSpc.-63-12891G>A
Exon rankIntron 1 of 7
intron
Prot: NP_570824.1UniProt: P60880-1
SNAP25 NM_001322902.2
HGVSc / HGVSpc.-63-12891G>A
Exon rankIntron 1 of 7
intron
Prot: NP_001309831.1UniProt: P60880-2
SNAP25 NM_001322903.2
HGVSc / HGVSpc.-63-12891G>A
Exon rankIntron 2 of 8
intron
Prot: NP_001309832.1UniProt: P60880-1

Ensembl Transcripts

SNAP25 ENST00000254976.7
TSL:1MANE Select
HGVSc / HGVSpc.-63-12891G>A
Exon rankIntron 1 of 7
intron
Prot: ENSP00000254976.3UniProt: P60880-1
SNAP25 ENST00000304886.6
TSL:1
HGVSc / HGVSpc.-63-12891G>A
Exon rankIntron 1 of 7
intron
Prot: ENSP00000307341.2UniProt: P60880-2
SNAP25 ENST00000961779.1
HGVSc / HGVSpc.-63-12891G>A
Exon rankIntron 1 of 8
intron
Prot: ENSP00000631838.1UniProt: A0ACI8V5C3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.362
AC:54938
Hom:10740
AN:151748
Cov:32
GnomAD4 genome
AF: 0.362
AC:54961
Hom:10738
AN:151862
Cov:32
TOPMed (Bravo)
AF: 0.359
AC:95068
Hom:18567
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.414
AC:114614
Hom:24178
AN:277014
Local & regional cohorts 8 sources
ABraOM SABE-WGS-1171
AF: 0.423
AC:988
Hom:228
AN:2334
ChinaMAP Phase 1
AF: 0.0961
Denmark Genome
AF: 0.447
AC:134
AN:300
Korea4K (4,157 Koreans)
AF: 0.118
AC:854
AN:7234
Qatari Genome
AF: 0.648
AC:114
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.138
AC:16883
Hom:1167
AN:122552
Turkish Variome
AF: 0.457
AC:707
Hom:170
AN:1546
UK10K
AF: 0.409
AC:3093
AN:7562
Showing 12 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign9.2
BayesDel_noAF
Benign-0.92
CADD
Benign1.8
DANN
Benign0.75
GPN-Star LLR
N/A2.3
GPN-Star score
N/A-1.9
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign0.14
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.